Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
10 /100
COMPONENT-LIMITED
Score updated Oct 13, 2026

RPRX — Royalty Pharma plc Dilution Risk Tracker

Track RPRX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track RPRX — Get alerts when the score changes →

As of October 13, 2026, Royalty Pharma plc (RPRX) has a DilutionWatch DilutionScore of 10/100, rated LOW dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Royalty Pharma plc has a market capitalization of $22.43B, 388.13M shares outstanding, 590 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
20
💰Cash Runway—
📊Float Risk—
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for RPRX.
🔔 Track RPRX — Get forecast alerts →

Market Data

Market Cap$22.43B
Shares Outstanding388.13M
FloatN/A
Cash$811.99M
Debt$8.96B
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore10/100DilutionWatch score record
Shares Outstanding388.13MVerified float table or market cache
Public FloatNot availableVerified float table or market cache
Market Cap$22.43BMarket data cache
Cash RunwayNot applicable / unavailableDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 5.

Recent SEC source mix: 4 5.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 26.8% shares (2026Q1 vs prior)
590 institutional holders · 476.56M shares
#1 MORGAN STANLEY 143.01M shares
#2 Capital International Investors 35.01M shares
#3 BlackRock, Inc. 25.91M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest12.89M
Days to Cover4.4
% of FloatN/A
FINRA data as of Sep 30, 2026

Recent SEC Activity

4 INSIDER TRANSACTION 2026-04-02
4 INSIDER TRANSACTION 2026-03-31
4 INSIDER TRANSACTION 2026-03-25
4 INSIDER TRANSACTION 2026-03-04
4 INSIDER TRANSACTION 2026-02-25
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual RPRX Dilution Snapshot

Royalty Pharma plc (RPRX) has a DilutionScore of 10/100, rated Low dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

RPRX's DilutionScore has held steady at 10/100 (Low risk) for 89 consecutive days across the tracked period.

Period Score Risk Level Duration
Jul 16 – Oct 13, 202610/100LOW89 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

RPRX shares outstanding have decreased 0.2% from 444.38M (Apr 2026) to 443.27M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 23, 2026443.27M410.36M▼ 5.61%
May 12, 2026443.27M434.81M▲ 3.47%
Apr 21, 2026444.38M420.22M▲ 6.69%
Apr 20, 2026444.38M393.88M▲ 0.33%
Apr 17, 2026444.38M392.59M▲ 0.02%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track RPRX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment RPRX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking RPRX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

More Research for RPRX
RPRX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.